Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor

NCT01556906 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Homozygous Familial Hypercholesterolemia

Interventions

DRUG: Lomitapide

Sponsor

Aegerion Pharmaceuticals, Inc.

Collaborators

[object Object]
[object Object]